{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:01:03Z","timestamp":1768568463528,"version":"3.49.0"},"posted":{"date-parts":[[2024,9,25]]},"group-title":"Dermatology","reference-count":45,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.medrxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,12,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Current approaches to selecting molecularly targeted therapies (biologics and oral small molecules) for immune-mediated skin diseases largely overlook interindividual immunologic heterogeneity, in part due to challenges of sample collection and the lack of broadly accepted biomarkers of therapeutic response. We sought to develop a rapid, minimally invasive method for obtaining and measuring biomarkers from skin and to generate predictive models of therapy response in two common inflammatory skin diseases, psoriasis and eczema. Here we present Detergent-based Immune Profiling System (DIPS), which enables painless and non-scarring collection of full thickness epidermal protein from skin and is suitable for downstream 45-plex immune protein biomarker analysis. We first developed machine learning models with the goal of accurately distinguishing between eczema (n=55) and psoriasis (n=74). Subsequently, models that correlate biomarker patterns with treatment response or nonresponse to commonly used biologic therapies were developed. We subsequently developed DIPS-Derm, a web-based platform that provides automated diagnostic and treatment predictions from data generated with DIPS. These results support the promise of artificial intelligence (AI)-driven precision dermatology and highlight the clinical potential of DIPS for personalized medicine in inflammatory skin disease.<\/jats:p>","DOI":"10.1101\/2024.09.24.24314282","type":"posted-content","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T13:45:20Z","timestamp":1727271920000},"source":"Crossref","is-referenced-by-count":0,"title":["Non-invasive epidermal proteomics and machine learning permits molecular subclassification of psoriasis and eczematous dermatitis"],"prefix":"10.64898","author":[{"given":"Yiwei","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Murphy","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Computer Science, Southern Connecticut State University, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gloria","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA"},{"name":"Department of Dermatology, University of California San Francisco, San Francisco, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Princess","family":"Edemobi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad H.","family":"Junejo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Mitchel","family":"Wride","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah L.","family":"Spaulding","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth Y.","family":"Tsai","sequence":"additional","affiliation":[{"name":"H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey M.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA"},{"name":"Department of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Damsky","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA"},{"name":"Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2026010105125136000_2024.09.24.24314282v2.1","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.446"},{"key":"2026010105125136000_2024.09.24.24314282v2.2","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-017-0603-3"},{"key":"2026010105125136000_2024.09.24.24314282v2.3","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jaad.2023.08.059","article-title":"Real-world effectiveness and safety of upadacitinib for the treatment of atopic dermatitis in adult patients switched from dupilumab: A multicenter retrospective study","volume":"89","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"2026010105125136000_2024.09.24.24314282v2.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1610020"},{"key":"2026010105125136000_2024.09.24.24314282v2.5","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-022-09356-y"},{"key":"2026010105125136000_2024.09.24.24314282v2.6","doi-asserted-by":"crossref","unstructured":"Trave I , Salvi I , Burlando M , Cozzani E , Parodi A . \u201cDe Novo\u201d Psoriasis and Relapse of Psoriasis Induced by Dupilumab: Three New Cases and Review of the Literature. J Clin Med 12, (2023).","DOI":"10.3390\/jcm12196291"},{"key":"2026010105125136000_2024.09.24.24314282v2.7","doi-asserted-by":"publisher","DOI":"10.1159\/000530608"},{"key":"2026010105125136000_2024.09.24.24314282v2.8","doi-asserted-by":"crossref","unstructured":"Quick AP , Hurton LV , Zolochevska O , Farberg AS , Goldberg MS , Silverberg JI . 707 - Contemporary systemic treatment patterns in atopic dermatitis. British Journal of Dermatology 191, (2024).","DOI":"10.1093\/bjd\/ljae266.081"},{"key":"2026010105125136000_2024.09.24.24314282v2.9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-13-472"},{"key":"2026010105125136000_2024.09.24.24314282v2.10","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.jaci.2021.10.022","article-title":"Advances in atopic dermatitis in 2019-2020: Endotypes from skin barrier, ethnicity, properties of antigen, cytokine profiles, microbiome, and engagement of immune cells","volume":"148","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"2026010105125136000_2024.09.24.24314282v2.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.10.032"},{"key":"2026010105125136000_2024.09.24.24314282v2.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2017.08.008"},{"key":"2026010105125136000_2024.09.24.24314282v2.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2021.100021"},{"key":"2026010105125136000_2024.09.24.24314282v2.14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jaci.2018.07.028","article-title":"Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab","volume":"143","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2026010105125136000_2024.09.24.24314282v2.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.12.052"},{"key":"2026010105125136000_2024.09.24.24314282v2.16","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-021-00655-y"},{"key":"2026010105125136000_2024.09.24.24314282v2.17","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljad389"},{"key":"2026010105125136000_2024.09.24.24314282v2.18","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-012-0071-5"},{"key":"2026010105125136000_2024.09.24.24314282v2.19","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-013-0128-0"},{"key":"2026010105125136000_2024.09.24.24314282v2.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.05.093"},{"key":"2026010105125136000_2024.09.24.24314282v2.21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s40257-016-0204-6","article-title":"Tolerability of Crisaborole Ointment for Application on Sensitive Skin Areas: A Randomized, Double-Blind, Vehicle-Controlled Study in Healthy Volunteers","volume":"17","year":"2016","journal-title":"Am J Clin Dermatol"},{"key":"2026010105125136000_2024.09.24.24314282v2.22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/exd.14441","article-title":"Skin atrophy caused by topical glucocorticoids is less common in patients with atopic dermatitis than in those with psoriasis","volume":"31","year":"2022","journal-title":"Exp Dermatol"},{"key":"2026010105125136000_2024.09.24.24314282v2.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.03.003"},{"key":"2026010105125136000_2024.09.24.24314282v2.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.12.018"},{"key":"2026010105125136000_2024.09.24.24314282v2.25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jdermsci.2025.05.006","article-title":"Mast cells express IL17A, IL17F and RORC in lesional psoriatic skin, are activated before therapy and persist in high numbers in a resting state with IL-17A positivity after treatment","volume":"119","year":"2025","journal-title":"J Dermatol Sci"},{"key":"2026010105125136000_2024.09.24.24314282v2.26","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-015-0208-5"},{"key":"2026010105125136000_2024.09.24.24314282v2.27","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.267"},{"key":"2026010105125136000_2024.09.24.24314282v2.28","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jid.2022.10.015","article-title":"IL-4\/IL-13 Inhibitors for Atopic Dermatitis Induce Psoriatic Rash Transcriptionally Close to Pustular Psoriasis","volume":"143","year":"2023","journal-title":"J Invest Dermatol"},{"key":"2026010105125136000_2024.09.24.24314282v2.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2023.06.194"},{"key":"2026010105125136000_2024.09.24.24314282v2.30","doi-asserted-by":"crossref","first-page":"1250504","DOI":"10.3389\/fimmu.2023.1250504","article-title":"Multi-omics segregate different transcriptomic impacts of anti-IL-17A blockade on type 17 T-cells and regulatory immune cells in psoriasis skin","volume":"14","year":"2023","journal-title":"Front Immunol"},{"key":"2026010105125136000_2024.09.24.24314282v2.31","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jaci.2021.04.021","article-title":"Single-cell transcriptomics applied to emigrating cells from psoriasis elucidate pathogenic versus regulatory immune cell subsets","volume":"148","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"2026010105125136000_2024.09.24.24314282v2.32","doi-asserted-by":"crossref","unstructured":"Bangert C , et al. Persistence of mature dendritic cells, T(H)2A, and Tc2 cells characterize clinically resolved atopic dermatitis under IL-4R\u03b1 blockade. Sci Immunol 6, (2021).","DOI":"10.1126\/sciimmunol.abe2749"},{"key":"2026010105125136000_2024.09.24.24314282v2.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.03.041"},{"key":"2026010105125136000_2024.09.24.24314282v2.34","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.jid.2023.05.011","article-title":"Transcriptomic Landscape of Prurigo Nodularis Lesional Skin CD3+ T Cells Using Single-Cell RNA Sequencing","volume":"143","year":"2023","journal-title":"J Invest Dermatol"},{"key":"2026010105125136000_2024.09.24.24314282v2.35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44994-w"},{"key":"2026010105125136000_2024.09.24.24314282v2.36","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.apsb.2024.12.041","article-title":"Celastrol directly targets LRP1 to inhibit fibroblast-macrophage crosstalk and ameliorates psoriasis progression","volume":"15","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"2026010105125136000_2024.09.24.24314282v2.37","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jaci.2021.07.025","article-title":"Single-cell analysis reveals innate lymphoid cell lineage infidelity in atopic dermatitis","volume":"149","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"2026010105125136000_2024.09.24.24314282v2.38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46540-0"},{"key":"2026010105125136000_2024.09.24.24314282v2.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.08.023"},{"key":"2026010105125136000_2024.09.24.24314282v2.40","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0000000000001711"},{"key":"2026010105125136000_2024.09.24.24314282v2.41","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s13555-025-01441-y","article-title":"Clinical Utility Findings of a Transcriptomic Psoriasis Biologic Test Demonstrate Altered Physician Prescribing Behavior and Improved Patient Outcomes","volume":"15","year":"2025","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2026010105125136000_2024.09.24.24314282v2.42","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1038\/s41467-025-59340-x","article-title":"An unbiased tissue transcriptome analysis identifies potential markers for skin phenotypes and therapeutic responses in atopic dermatitis","volume":"16","year":"2025","journal-title":"Nat Commun"},{"key":"2026010105125136000_2024.09.24.24314282v2.43","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abl9165"},{"key":"2026010105125136000_2024.09.24.24314282v2.44","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s13555-022-00733-x","article-title":"Minimally Invasive Skin Transcriptome Extraction Using a Dermal Biomarker Patch","volume":"12","year":"2022","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2026010105125136000_2024.09.24.24314282v2.45","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s13555-021-00573-1","article-title":"A Survey of Community Dermatologists Reveals the Unnecessary Impact of Trial-and-Error Behavior on the Psoriasis Biologic Treatment Paradigm","volume":"11","year":"2021","journal-title":"Dermatol Ther (Heidelb)"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.09.24.24314282","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:13:00Z","timestamp":1768507980000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2024.09.24.24314282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,25]]},"references-count":45,"URL":"https:\/\/doi.org\/10.1101\/2024.09.24.24314282","relation":{},"subject":[],"published":{"date-parts":[[2024,9,25]]},"subtype":"preprint"}}